New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration

Saved in:
Bibliographic Details
Published inThe Journal of pharmacology and experimental therapeutics Vol. 363; no. 1; pp. 92 - 103
Main Authors Salaga, Maciej, Mokrowiecka, Anna, Zielinska, Marta, Malecka-Panas, Ewa, Kordek, Radzislaw, Kamysz, Elzbieta, Fichna, Jakub
Format Journal Article
LanguageEnglish
Japanese
Published 01.10.2017
Online AccessGet full text

Cover

Author Kordek, Radzislaw
Malecka-Panas, Ewa
Mokrowiecka, Anna
Salaga, Maciej
Zielinska, Marta
Fichna, Jakub
Kamysz, Elzbieta
Author_xml – sequence: 1
  givenname: Maciej
  surname: Salaga
  fullname: Salaga, Maciej
– sequence: 2
  givenname: Anna
  surname: Mokrowiecka
  fullname: Mokrowiecka, Anna
– sequence: 3
  givenname: Marta
  surname: Zielinska
  fullname: Zielinska, Marta
– sequence: 4
  givenname: Ewa
  surname: Malecka-Panas
  fullname: Malecka-Panas, Ewa
– sequence: 5
  givenname: Radzislaw
  surname: Kordek
  fullname: Kordek, Radzislaw
– sequence: 6
  givenname: Elzbieta
  surname: Kamysz
  fullname: Kamysz, Elzbieta
– sequence: 7
  givenname: Jakub
  surname: Fichna
  fullname: Fichna, Jakub
BookMark eNp1kEtPAjEUhbvAREDXbvsDHOhrXksEBBJQFuh20mlvQ8nQmUxr1N_hH3Z4rExc3ZN7z3dzcgao52oHCD1QMqKUifGhgdCpdMQEi7Okh_qEMBbxOIlv0cD7AyFUiIT30c8LfOItNMFqwCu3t6UNdYtrg2e2Oa-_q-td-s7x_ojnm9lTRPH8K4DTHoc94KWsTLS2Bk7gYr2NGJZO40noLB8ygMfTurLBemwd3lgFWJoALd7VjVWywhN9tM760Mpga3eHboysPNxf5xC9Pc9302W0fl2sppN1pGjOk8gAi3OuuSYlL5nIYgrC6CyLIeOlKKnMNTNpCjkQbWgmFU840VyIWOUKtORDFF_-qrb2vgVTKBvOCbogtiooKU5tFqc2O5UWlzY7bvyHa1p7lO33v8Qv9bd9Cw
CitedBy_id crossref_primary_10_3389_fmicb_2023_1174308
crossref_primary_10_1007_s11033_020_06095_x
crossref_primary_10_1007_s43440_021_00327_y
crossref_primary_10_1016_j_ejmech_2022_114697
crossref_primary_10_2139_ssrn_4149499
crossref_primary_10_1016_j_jphs_2019_05_003
crossref_primary_10_3389_fmicb_2018_01900
crossref_primary_10_1016_j_jid_2024_03_017
crossref_primary_10_1016_j_lfs_2021_119295
crossref_primary_10_1016_j_pharmthera_2020_107503
crossref_primary_10_1016_j_peptides_2019_170223
crossref_primary_10_3390_metabo12010031
crossref_primary_10_3389_fphar_2021_720703
crossref_primary_10_1007_s10787_023_01227_8
crossref_primary_10_1016_j_peptides_2018_08_011
crossref_primary_10_1038_s41575_022_00604_y
crossref_primary_10_1016_j_intimp_2021_107845
crossref_primary_10_1038_s41401_020_0413_7
crossref_primary_10_1111_1440_1681_13361
crossref_primary_10_1007_s00210_019_01698_z
crossref_primary_10_1002_fsn3_4426
crossref_primary_10_1093_ibd_izaa324
crossref_primary_10_1016_j_snb_2023_134358
crossref_primary_10_1021_acs_jmedchem_9b01649
Cites_doi 10.1053/gast.2001.23252
10.1210/endo.141.11.7752
10.1097/00054725-200407000-00023
10.1136/gut.2006.102780
10.3109/00365521.2013.832366
10.1016/j.peptides.2015.07.025
10.1177/2050640614550672
10.1111/j.1747-0285.2006.00425.x
10.1016/S0140-6736(07)60750-8
10.1016/j.neuropharm.2011.07.021
10.1007/s00535-013-0753-x
10.1016/j.crohns.2014.01.025
10.1053/j.gastro.2011.10.001
10.1053/j.gastro.2012.07.016
10.1016/j.intimp.2006.09.014
10.1111/bph.13212
10.4161/gmic.29330
10.1016/j.bcp.2014.09.018
10.1124/jpet.105.099986
10.1124/jpet.109.161497
10.1210/en.2009-0295
10.1158/0008-5472.CAN-08-0029
10.2741/3193
10.1111/j.1747-0285.2010.00977.x
10.1155/2013/460958
10.1517/14728222.2011.556620
10.1016/j.neuroscience.2007.12.005
10.1097/01.MIB.0000440815.76627.64
10.1016/j.peptides.2014.08.005
10.1016/j.phrs.2015.07.005
10.1136/gutjnl-2015-309147
10.1016/j.drudis.2013.03.004
10.1172/JCI200316750
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1124/jpet.117.242586
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EndPage 103
ExternalDocumentID 10_1124_jpet_117_242586
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
2WC
3O-
4.4
53G
5GY
5RE
5VS
8WZ
A6W
AALRI
AAXUO
AAYOK
AAYXX
ABCQX
ABIVO
ABJNI
ABOCM
ABSQV
ACGFO
ACGFS
ACNCT
ACVFH
ADBBV
ADCNI
ADCOW
AENEX
AERNN
AETEA
AEUPX
AFFNX
AFOSN
AFPUW
AGFXO
AI.
AIGII
AKBMS
AKYEP
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
F9R
FDB
GX1
H13
HZ~
INIJC
KQ8
L7B
LSO
M41
MJL
MVM
O9-
OHT
P2P
R.V
R0Z
RHI
ROL
RPT
TR2
UQL
VH1
W8F
WH7
WOQ
X7M
YBU
YHG
YQT
ZGI
ZXP
ID FETCH-LOGICAL-c1936-fe2593d3d0b3b24851e4fd885e83b4b1a9d2f77e9e0df18ac3630d3445c9ceda3
ISSN 0022-3565
IngestDate Tue Jul 01 05:39:02 EDT 2025
Thu Apr 24 23:03:56 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1936-fe2593d3d0b3b24851e4fd885e83b4b1a9d2f77e9e0df18ac3630d3445c9ceda3
OpenAccessLink https://jpet.aspetjournals.org/content/jpet/363/1/92.full.pdf
PageCount 12
ParticipantIDs crossref_citationtrail_10_1124_jpet_117_242586
crossref_primary_10_1124_jpet_117_242586
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-10-00
PublicationDateYYYYMMDD 2017-10-01
PublicationDate_xml – month: 10
  year: 2017
  text: 2017-10-00
PublicationDecade 2010
PublicationTitle The Journal of pharmacology and experimental therapeutics
PublicationYear 2017
References Iakoubov (10.1124/jpet.117.242586_bib11) 2009; 150
Bank (10.1124/jpet.117.242586_bib1) 2006; 6
Sałaga (10.1124/jpet.117.242586_bib24) 2013; 18
Fichna (10.1124/jpet.117.242586_bib6) 2006; 68
Martín (10.1124/jpet.117.242586_bib14) 2014; 20
O’Hara (10.1124/jpet.117.242586_bib20) 2007; 56
Mimura (10.1124/jpet.117.242586_bib15) 2013; 48
Koehler (10.1124/jpet.117.242586_bib13) 2008; 68
Hartmann (10.1124/jpet.117.242586_bib9) 2000; 141
Sans (10.1124/jpet.117.242586_bib28) 2001; 120
Börzsei (10.1124/jpet.117.242586_bib3) 2008; 152
Cravezic (10.1124/jpet.117.242586_bib4) 2011; 61
Raine (10.1124/jpet.117.242586_bib22) 2014; 2
Baumgart (10.1124/jpet.117.242586_bib2) 2007; 369
Fichna (10.1124/jpet.117.242586_bib7) 2010; 76
Geuking (10.1124/jpet.117.242586_bib8) 2014; 5
Yazbeck (10.1124/jpet.117.242586_bib33) 2008; 13
Jump (10.1124/jpet.117.242586_bib12) 2004; 10
Fichna (10.1124/jpet.117.242586_bib5) 2006; 317
Philippe (10.1124/jpet.117.242586_bib21) 2003; 111
Sigalet (10.1124/jpet.117.242586_bib29) 2013; 27
Sałaga (10.1124/jpet.117.242586_bib26) 2014; 92
Nakame (10.1124/jpet.117.242586_bib19) 2016; 75
Molodecky (10.1124/jpet.117.242586_bib16) 2012; 142
Sobczak (10.1124/jpet.117.242586_bib30) 2014; 60
Sałaga (10.1124/jpet.117.242586_bib25) 2014; 8
Hornby (10.1124/jpet.117.242586_bib10) 2011; 15
Rogler (10.1124/jpet.117.242586_bib23) 2015; 100
Salaga (10.1124/jpet.117.242586_bib27) 2015; 172
Monteleone (10.1124/jpet.117.242586_bib17) 2012; 143
Sobczak (10.1124/jpet.117.242586_bib31) 2014; 49
Vergnolle (10.1124/jpet.117.242586_bib32) 2016; 65
Moore (10.1124/jpet.117.242586_bib18) 2010; 333
References_xml – volume: 120
  start-page: 1162
  year: 2001
  ident: 10.1124/jpet.117.242586_bib28
  article-title: Differential role of selectins in experimental colitis
  publication-title: Gastroenterology
  doi: 10.1053/gast.2001.23252
– volume: 141
  start-page: 4013
  year: 2000
  ident: 10.1124/jpet.117.242586_bib9
  article-title: Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice
  publication-title: Endocrinology
  doi: 10.1210/endo.141.11.7752
– volume: 10
  start-page: 462
  year: 2004
  ident: 10.1124/jpet.117.242586_bib12
  article-title: Mechanisms of natural tolerance in the intestine: implications for inflammatory bowel disease
  publication-title: Inflamm Bowel Dis
  doi: 10.1097/00054725-200407000-00023
– volume: 56
  start-page: 186
  year: 2007
  ident: 10.1124/jpet.117.242586_bib20
  article-title: Ileitis alters neuronal and enteroendocrine signalling in guinea pig distal colon
  publication-title: Gut
  doi: 10.1136/gut.2006.102780
– volume: 48
  start-page: 1152
  year: 2013
  ident: 10.1124/jpet.117.242586_bib15
  article-title: Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis
  publication-title: Scand J Gastroenterol
  doi: 10.3109/00365521.2013.832366
– volume: 75
  start-page: 1
  year: 2016
  ident: 10.1124/jpet.117.242586_bib19
  article-title: The protective and anti-inflammatory effects of glucagon-like peptide-2 in an experimental rat model of necrotizing enterocolitis
  publication-title: Peptides
  doi: 10.1016/j.peptides.2015.07.025
– volume: 2
  start-page: 333
  year: 2014
  ident: 10.1124/jpet.117.242586_bib22
  article-title: Vedolizumab for inflammatory bowel disease: changing the game, or more of the same?
  publication-title: United European Gastroenterol J
  doi: 10.1177/2050640614550672
– volume: 68
  start-page: 173
  year: 2006
  ident: 10.1124/jpet.117.242586_bib6
  article-title: In vitro characterization of novel peptide inhibitors of endomorphin-degrading enzymes in the rat brain
  publication-title: Chem Biol Drug Des
  doi: 10.1111/j.1747-0285.2006.00425.x
– volume: 369
  start-page: 1627
  year: 2007
  ident: 10.1124/jpet.117.242586_bib2
  article-title: Inflammatory bowel disease: cause and immunobiology
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)60750-8
– volume: 61
  start-page: 1229
  year: 2011
  ident: 10.1124/jpet.117.242586_bib4
  article-title: Effect of potent endomorphin degradation blockers on analgesic and antidepressant-like responses in mice
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2011.07.021
– volume: 49
  start-page: 24
  year: 2014
  ident: 10.1124/jpet.117.242586_bib31
  article-title: Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-013-0753-x
– volume: 8
  start-page: 998
  year: 2014
  ident: 10.1124/jpet.117.242586_bib25
  article-title: Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)
  publication-title: J Crohn’s Colitis
  doi: 10.1016/j.crohns.2014.01.025
– volume: 142
  start-page: 46
  year: 2012
  ident: 10.1124/jpet.117.242586_bib16
  article-title: Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2011.10.001
– volume: 143
  start-page: 1277
  year: 2012
  ident: 10.1124/jpet.117.242586_bib17
  article-title: Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestine
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2012.07.016
– volume: 6
  start-page: 1925
  year: 2006
  ident: 10.1124/jpet.117.242586_bib1
  article-title: Triggering endogenous immunosuppressive mechanisms by combined targeting of dipeptidyl peptidase IV (DPIV/CD26) and aminopeptidase N (APN/ CD13)—a novel approach for the treatment of inflammatory bowel disease
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2006.09.014
– volume: 172
  start-page: 4331
  year: 2015
  ident: 10.1124/jpet.117.242586_bib27
  article-title: Salvinorin A analogues PR-37 and PR-38 attenuate compound 48/80-induced itch responses in mice
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.13212
– volume: 5
  start-page: 411
  year: 2014
  ident: 10.1124/jpet.117.242586_bib8
  article-title: The interplay between the gut microbiota and the immune system
  publication-title: Gut Microbes
  doi: 10.4161/gmic.29330
– volume: 92
  start-page: 618
  year: 2014
  ident: 10.1124/jpet.117.242586_bib26
  article-title: Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2014.09.018
– volume: 317
  start-page: 1150
  year: 2006
  ident: 10.1124/jpet.117.242586_bib5
  article-title: Functional characterization of opioid receptor ligands by aequorin luminescence-based calcium assay
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.105.099986
– volume: 333
  start-page: 574
  year: 2010
  ident: 10.1124/jpet.117.242586_bib18
  article-title: GLP-2 receptor agonism ameliorates inflammation and gastrointestinal stasis in murine postoperative ileus
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.109.161497
– volume: 150
  start-page: 4033
  year: 2009
  ident: 10.1124/jpet.117.242586_bib11
  article-title: Carcinogenic effects of exogenous and endogenous glucagon-like peptide-2 in azoxymethane-treated mice
  publication-title: Endocrinology
  doi: 10.1210/en.2009-0295
– volume: 68
  start-page: 7897
  year: 2008
  ident: 10.1124/jpet.117.242586_bib13
  article-title: Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-0029
– volume: 13
  start-page: 6850
  year: 2008
  ident: 10.1124/jpet.117.242586_bib33
  article-title: Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice
  publication-title: Front Biosci
  doi: 10.2741/3193
– volume: 76
  start-page: 77
  year: 2010
  ident: 10.1124/jpet.117.242586_bib7
  article-title: The novel endomorphin degradation blockers Tyr-Pro-DClPhe-Phe-NH (EMDB-1) and Tyr-Pro-Ala-NH (EMDB-2) prolong endomorphin-2 action in rat ileum in vitro
  publication-title: Chem Biol Drug Des
  doi: 10.1111/j.1747-0285.2010.00977.x
– volume: 27
  start-page: 587
  year: 2013
  ident: 10.1124/jpet.117.242586_bib29
  article-title: A pilot study examining the relationship among Crohn disease activity, glucagon-like peptide-2 signalling and intestinal function in pediatric patients
  publication-title: Can J Gastroenterol
  doi: 10.1155/2013/460958
– volume: 15
  start-page: 637
  year: 2011
  ident: 10.1124/jpet.117.242586_bib10
  article-title: The therapeutic potential of targeting the glucagon-like peptide-2 receptor in gastrointestinal disease
  publication-title: Expert Opin Ther Targets
  doi: 10.1517/14728222.2011.556620
– volume: 152
  start-page: 82
  year: 2008
  ident: 10.1124/jpet.117.242586_bib3
  article-title: Inhibitory action of endomorphin-1 on sensory neuropeptide release and neurogenic inflammation in rats and mice
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2007.12.005
– volume: 20
  start-page: 417
  year: 2014
  ident: 10.1124/jpet.117.242586_bib14
  article-title: The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models
  publication-title: Inflamm Bowel Dis
  doi: 10.1097/01.MIB.0000440815.76627.64
– volume: 60
  start-page: 102
  year: 2014
  ident: 10.1124/jpet.117.242586_bib30
  article-title: Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: new potential treatment of abdominal pain associated with inflammatory bowel diseases
  publication-title: Peptides
  doi: 10.1016/j.peptides.2014.08.005
– volume: 100
  start-page: 220
  year: 2015
  ident: 10.1124/jpet.117.242586_bib23
  article-title: Where are we heading to in pharmacological IBD therapy?
  publication-title: Pharmacol Res
  doi: 10.1016/j.phrs.2015.07.005
– volume: 65
  start-page: 1215
  year: 2016
  ident: 10.1124/jpet.117.242586_bib32
  article-title: Protease inhibition as new therapeutic strategy for GI diseases
  publication-title: Gut
  doi: 10.1136/gutjnl-2015-309147
– volume: 18
  start-page: 708
  year: 2013
  ident: 10.1124/jpet.117.242586_bib24
  article-title: Inhibition of proteases as a novel therapeutic strategy in the treatment of metabolic, inflammatory and functional diseases of the gastrointestinal tract
  publication-title: Drug Discov Today
  doi: 10.1016/j.drudis.2013.03.004
– volume: 111
  start-page: 1329
  year: 2003
  ident: 10.1124/jpet.117.242586_bib21
  article-title: Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation
  publication-title: J Clin Invest
  doi: 10.1172/JCI200316750
SSID ssj0014463
Score 2.159269
SourceID crossref
SourceType Enrichment Source
Index Database
StartPage 92
Title New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration
Volume 363
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKeOEFcRUbF50HNCGtLrm4TfI4WKGDFRXRTRMvlZ04IrRKqq7VNP4G_45fw_GlTjp10uAlap3Yavt99bn4XAh5jVJGRqkX0V6cMMqCyKexkJKibBciSpTQVX7I4Zfe4JR9Ou-et1p_GlFLq6XopL-25pX8D6o4hriqLNl_QNYtigP4GvHFKyKM11thrIITRyosJVMRkD8KgX9P7fU_KuZ6-Gpm76OsOjg-M66Wo3fUP-hr5_eF1jsHfJbTkyLX7oOPJyMa6COFwyU-slK6qHIvqNpHyjkyLFSKge4sPq7mBuKNArxNdbdOPNMq77yuk23KPm30F2ikgjlF_xufceP6HXLchX46flTTRXVZyHRq_MJl6cTL90Kl2F9M7azF0t0ZojDECXTES5PG1r_kTa8HStJ1_NxmFoLpM7HeyUO7VzYpa_Zl02_PSnhfV1XYIjwCpoQHWivqKLujjLFtZbqviU8X1KjNqYBN1AKqhvrELHCH3A3QhFHdNT5_rU-40AwPXSV7_B627BQu8PbaJ2hoTA3VZ_yA3LcAwqEh4EPSkuUjsj8yYF61YdwArg37MGrA_Jj8RpaCZSk4lkKVQ81ScCyF47M2GI6C5SggMcBxVE3UHAUkENQcBctRKEpQHAXNUbAchU2OPiGnH_rj9wNqW4HQFC2MHs0lmulhFmaeCIWqwudLlmdx3JVxKJjweZIFeRTJRHpZ7sc8RSp4WchYN01SmfHwKdkpq1I-I5AGsfRjFqRJHjGPdwXHN1k38XoyjxIe7ZLO-ueepLZOvmrXMpvcAPAueeMmzE2JmJse3bv9o8_JvZr3L8jOcrGSL1H_XYpXmkh_AU4osy4
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=New+Peptide+Inhibitor+of+Dipeptidyl+Peptidase+IV%2C+EMDB-1+Extends+the+Half-Life+of+GLP-2+and+Attenuates+Colitis+in+Mice+after+Topical+Administration&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=Salaga%2C+Maciej&rft.au=Mokrowiecka%2C+Anna&rft.au=Zielinska%2C+Marta&rft.au=Malecka-Panas%2C+Ewa&rft.date=2017-10-01&rft.issn=0022-3565&rft.volume=363&rft.issue=1&rft.spage=92&rft.epage=103&rft_id=info:doi/10.1124%2Fjpet.117.242586&rft.externalDBID=n%2Fa&rft.externalDocID=10_1124_jpet_117_242586
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon